Human hair

Colorsmith™ Custom At-Home Hair Colour For Men Expands Across Europe, Leading The Future Of Grooming

Retrieved on: 
Thursday, June 24, 2021
Color, Optical spectrum, Human hair, Web colors, Grey, eSalon, Human hair color, Branches of biology, Perception, Sensory systems

Powered by patented colour-mixing technology, Colorsmith was created by the makers of award-winning hair colour company eSalon , which has revolutionised women's home hair colour for over a decade.

Key Points: 
  • Powered by patented colour-mixing technology, Colorsmith was created by the makers of award-winning hair colour company eSalon , which has revolutionised women's home hair colour for over a decade.
  • Grounded in tech and colour theory, Colorsmith is for every man no matter where they are on their hair colour journey.
  • Colorsmith offers a completely custom and effortless home hair colour experience for men with options for natural-looking grey coverage on their terms.
  • Colorsmith was created by the team behind award-winning hair colour company eSalon and is powered by state-of-the-art, dual-patented technology.

Worldwide Hair Loss Treatment Industry to 2027 - Impact Analysis of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 17, 2021
General Health, Pharmaceutical, Health, Organ systems, Hair diseases, Human hair, Organs anatomy), Anatomy, Pattern hair loss, Hair loss, Kinking hair, Traction alopecia

The "Hair Loss Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hair Loss Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • Hair loss is a common condition and it can be caused by numerous disorders.
  • In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.
  • Rising incidence of androgenetic alopecia is expected to drive the global hair loss treatment market growth.

Insights on the Minoxidil Global Market to 2027 - Players Include Pfizer, Remedy Repack and Incredible Products Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 17, 2021
Retail, General Health, Specialty, Health, Organ systems, Organs anatomy), Hair diseases, Human hair, Minoxidil, Piperidines, Pattern hair loss, Hair loss, Management of hair loss, Non scarring hair loss

The "Minoxidil Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Minoxidil Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • Minoxidil is an antihypertensive available in topical as well as oral solution used for hair loss treatment.
  • This drug is U.S. Food & Drug Administration (U.S. FDA) approved for androgenetic alopecia and female pattern hair loss.
  • Rising incidence of androgenetic alopecia is expected to drive the global minoxidil market growth.

Global Hair Transplant Market Forecast 2020-2021 & 2027 by Methods, Products, Therapy, Gender, Service Provider, Region, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 17, 2021
Surgery, Health, Medical specialties, Organ systems, Clinical medicine, Cosmetic surgery, Human hair, Transplantation medicine, Hair transplantation, Hair loss, Organ transplantation, Hair, Follicular unit transplantation, Eyelash implants

Global Hair Transplant Market is expected to reach US$ 27.9 Billion by 2027, from US$ 6 Billion in 2020

Key Points: 
  • Global Hair Transplant Market is expected to reach US$ 27.9 Billion by 2027, from US$ 6 Billion in 2020
    Hair transparent is a surgical procedure to treat baldness and hair removal.
  • The hair transplant process consists of removing tiny hair-follicles grafts from a donor site and transplanting these follicles to a bald or thinning area known as the 'recipient site.
  • According to the publisher,
    Along with North America, some developing countries are also witnessing significant hair transplant market growth.
  • Besides, there are various types of Hair Transplant products in the market like Gel, Serum, Drugs, and Multivitamins.

Celebrity Hairstylist Tacara Renee Launches New Hair Care System

Retrieved on: 
Monday, June 7, 2021
Plants, Hairdressing, Organisms, World Geographical Scheme for Recording Plant Distributions, Human hair, Hair care, Hygiene, Shampoo, Hair, Coconut, Conditioner, Human hair growth

CHICAGO, June 7, 2021 /PRNewswire/ -- Celebrity hair stylist Tacara Renee of Chicago-based Renee Ramore Hair Care today launches an entirely new coconut-infused, three-part hair care system that richly hydrates all types of hair without affecting unique hair texture.

Key Points: 
  • CHICAGO, June 7, 2021 /PRNewswire/ -- Celebrity hair stylist Tacara Renee of Chicago-based Renee Ramore Hair Care today launches an entirely new coconut-infused, three-part hair care system that richly hydrates all types of hair without affecting unique hair texture.
  • According to Tacara, the new Coconut Infused Renee Ramore Hair Care System is not just a product, but a scientifically advanced, three-part hair therapy system.
  • Renee Ramore Coconut Infused Hair Care System consists of a three-part, professionally developed hydrating hair care system shampoo, conditioner, and leave-in each infused with coconut oil and other natural oils that promote hair growth and length retention while leaving hair smooth, soft, and shiny.
  • Celebrating its second Anniversary, Renee Ramore Hair Care is designed for women and girls seeking beautiful, effortless hair and its coconut infused system revitalizes all hair types, while adding lasting moisture to all hair textures.

Hims & Hers Now Offering a Dual-Action Topical Hair Loss Treatment for Men

Retrieved on: 
Wednesday, June 2, 2021
Technology, MEN, General Health, Fitness & Nutrition, Consumer, Other Retail, Alternative medicine, Health, Specialty, Cosmetics, Retail, Other Health, Internet, Other Consumer, Women, Pharmaceutical, Online Retail, Organ systems, Hair diseases, Human hair, Hair removal, Finasteride, Teratogens, Minoxidil, Hair loss, Pattern hair loss, Hims & Hers Health, Scalp reduction

The Topical Finasteride & Minoxidil Spray is a pill-free prescription alternative to traditional oral finasteride treatment that provides effective support for male pattern hair loss.

Key Points: 
  • The Topical Finasteride & Minoxidil Spray is a pill-free prescription alternative to traditional oral finasteride treatment that provides effective support for male pattern hair loss.
  • The latest in a long list of high quality personalized wellness treatments available through the Hims & Hers telehealth platform, the combination of ingredients is specifically formulated to stop hair loss and regrow hair.
  • With the addition of prescription Topical Finasteride & Minoxidil Spray, Hims is a leader in providing customizable offerings for hair loss in men, said Hims & Hers Chief Medical Officer Dr. Patrick Carroll.
  • Hims suite of hair loss products can provide a high level of personalization for men who are seeking the optimal treatment for their own hair loss journey.

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

Retrieved on: 
Wednesday, June 2, 2021
Organ systems, Human hair, Hair diseases, Anatomy, Alopecia areata, Hair loss, Pattern hair loss, Telogen effluvium, Non scarring hair loss, Alopecia universalis

*

Key Points: 
  • *
    Introducing the most advanced genetic test supporting assessment and treatment of hair loss: TrichoTest, by Fagron.
  • TrichoTestis a genetic test performed on patients'DNA that analyzes 13 genes and 48 genetic variations related to alopecia, including androgenetic alopecia, alopecia areata, and telogen effluvium.
  • If left untreated, hair loss usually progresses over time.TrichoTestis the most complete genetic test for alopecia, analyzinggenetic factors and other relevant patient characteristics.
  • Today,TrichoTestis the only complete genetic test for alopecia and hereditary hair lossin the US market.

Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Retrieved on: 
Thursday, May 27, 2021
Biotechnology, Pharmaceutical, Health, Clinical trials, Organ systems, Hair diseases, Human hair, Anatomy, Autoimmune diseases, Alopecia areata, Hair loss, Janus kinase inhibitor, the THRIVE-AA2 Study, CTP-543 and Alopecia Areata, Concert, THE THRIVE-AA2 STUDY, CTP-543 AND ALOPECIA AREATA, CONCERT

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA2, the second planned Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata.

Key Points: 
  • Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA2, the second planned Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata.
  • We expect the CTP-543 THRIVE-AA clinical program to provide the pivotal data needed to support our registration, said James V. Cassella, Ph.D., Chief Development Officer of Concert Pharmaceuticals.
  • The continued support of the alopecia areata community has been essential in progressing our program, and the initiation of this second Phase 3 trial brings us another step closer to seeking FDA-approval.
  • The FDA has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

Vantis Institute Combines Entertainment and Education In National Hair Loss Campaign

Retrieved on: 
Friday, May 21, 2021
Organ systems, Human hair, Hair diseases, Vantis, Hair loss, Hair, Follicle, Surgery

b'NEWPORT BEACH, Calif., May 21, 2021 /PRNewswire-PRWeb/ -- Vantis Institute , the fast-growing hair loss clinic bringing non-surgical solutions to clients worldwide, announced its first-ever national ad spot.

Key Points: 
  • b'NEWPORT BEACH, Calif., May 21, 2021 /PRNewswire-PRWeb/ -- Vantis Institute , the fast-growing hair loss clinic bringing non-surgical solutions to clients worldwide, announced its first-ever national ad spot.
  • "Our goal is to change the lives of men and women suffering from hair loss.
  • "\nThe ad is currently available on YouTube.\nVantis Institute in Newport Beach developed an innovative solution for people suffering from hair loss.
  • Vantis Institute disrupted the industry with the development of a non-surgical hair-loss solution, called Vantis Follicle Replication (VFR).\n'

Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp

Retrieved on: 
Friday, May 21, 2021
Organ systems, Integumentary system, Actinic keratosis, Dermatology, Anatomy, Tirbanibulin, Scalp, Hair diseases, Human hair, Hair loss, Keratosis

Enrollment of patients was controlled to achieve a 2:1 ratio of facial: scalp treatment areas.

Key Points: 
  • Enrollment of patients was controlled to achieve a 2:1 ratio of facial: scalp treatment areas.
  • Two phase III studies (KX01-AK-003 and KX01-AK-004) evaluated the efficacy and safety of tirbanibulin ointment 1% (10 mg/g) in adults with actinic keratosis on the face or scalp.
  • It is usually found on the face, ears, lips, bald scalp, forearms, the posterior part of the hands, and lower legs.
  • Athenex\xe2\x80\x99s employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments.